| Original language | English |
|---|---|
| Pages (from-to) | 509-511 |
| Number of pages | 3 |
| Journal | Movement disorders |
| Volume | 38 |
| Issue number | 3 |
| Early online date | 2022 |
| DOIs | |
| Publication status | Published - Mar 2023 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Movement disorders, Vol. 38, No. 3, 03.2023, p. 509-511.
Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Concerns About the European Academy's Recommendations and Guidelines Regarding Pallidotomy for Parkinson's Disease
T2 - Let's Be Accurate
AU - Hariz, Marwan
AU - Bronstein, Jeff M.
AU - Cosgrove, G. Rees
AU - de Bie, Rob M. A.
AU - DeLong, Mahlon R.
AU - Gross, Robert E.
AU - Krack, Paul
AU - Krauss, Joachim K.
AU - Lang, Anthony E.
AU - Lees, Andrew J.
AU - Lozano, Andres M.
AU - Obeso, José A.
AU - Schuurman, P. Richard
AU - Vitek, Jerold L.
N1 - Funding Information: received honoraria from Boston Scientific for lecturing. received funding as site investigator from AbbVie Inc., Alexion Pharmaceuticals, Ultragenix Inc., and UC WorldMeds; has also received funding from the National Institute of Environmental Health Sciences (R01 ES031106 01A1). received clinical research support from Insightec. received research grants from Neuroderm, Medtronic, and Parkinson Vereniging. no disclosures to report. consultant for Medtronic, PLC and Abbot Laboratories. grants from Swiss National Science Foundation, Roger de Spoelberch Foundation, Bertarelli Foundation, Annemarie Opprecht Foundation, Parkinson Schweiz, The Michael J. Fox Foundation, Aleva Neurotherapeutics, and Boston Scientific; personal fees (lecturing fees to employing institution/travel expenses to scientific meetings) from Boston Scientific, Bial, and Zambon outside the submitted work. consultant to Medtronic. He received honoraria for speaking from St. Jude. Grants were obtained from DFG (German Research Foundation). funding from AbbVie, Alector, Amylyx, Biogen, BioAdvance, Biohaven, BlueRock, BMS, CoA Therapeutics, Denali, Janssen, Jazz, Lilly, Paladin, Retrophin, Roche, Sun Pharma, and UCB. is funded by the Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, University College London, and reports consultancies from Britannia Pharmaceuticals and BIAL. He also reports grants and/or research support from the Frances and Renee Hock Fund and honoraria from Britannia Pharmaceuticals, Profile Pharma, UCB, Roche, BIAL, STADA, NordicInfu Care, and NeuroDerm. consultant to Abbott, Boston Scientific, Medtronic, and Functional Neuromodulation. no disclosures to report. consultant for Medtronic and Boston Scientific on educational matters. serves as a consultant for Cala Health, Medtronic, Boston Scientific, and Abbott. He also serves on the Executive Advisory Board for Abbott and is a member of the scientific advisory board for Surgical Information Sciences. He has research support through the National Institutes of Health. Marwan Hariz: Jeff M. Bronstein: G. Rees Cosgrove: Rob M. A. de Bie: Mahlon R. DeLong: Robert Gross: Paul Krack: Joachim K. Krauss: Anthony E. Lang: Andrew J. Lees: Andres M. Lozano: José A. Obeso: P. Richard Schuurman: Jerold L. Vitek:
PY - 2023/3
Y1 - 2023/3
UR - http://www.scopus.com/inward/record.url?scp=85137330863&partnerID=8YFLogxK
U2 - 10.1002/mds.29210
DO - 10.1002/mds.29210
M3 - Article
C2 - 36047463
SN - 0885-3185
VL - 38
SP - 509
EP - 511
JO - Movement disorders
JF - Movement disorders
IS - 3
ER -